Diana Ernst, RPh

A study presented at the Academy of Managed Care Pharmacy Managed Care and Specialty Pharmacy 2019 Annual Meeting showed that an oral oncology split-fill program implemented by AllianceRx Walgreens Prime resulted in improved adherence and reduced pharmacy costs and medication waste.

An authorized generic of Flector Patch (diclofenac epolamine topical patch) has been made available by Teva Pharmaceuticals for the topical treatment of acute pain due to minor strains, sprains, and contusions.

The Food and Drug Administration (FDA) has approved Lotemax SM (loteprednol etabonate ophthalmic gel) 0.38% for the treatment of postoperative inflammation and pain following ocular surgery.

Tanezumab, an investigational subcutaneously-administered, non-opioid treatment, may benefit patients with moderate to severe chronic low back pain (CLBP), according to top-line results from a Phase 3 study.